Norway· NO-ID_936C27BE-3179-472F-9C19-01C0265DC6FC
Nulojix
A belatacept product containing belatacept, registered in Norway by Bristol-Myers Squibb Pharma EEIG. The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Belatacept is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AA28 (belatacept), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Belatacept · ATC L04AA28
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of belatacept costs, country by country.
Normalised to the WHO defined daily dose (12.5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Belatacept · price per daily dose (12.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$32.75
The record
At a glance
FEST (Norway)- Active substance
- Belatacept
- Manufacturer
- Bristol-Myers Squibb Pharma EEIG
- Country
- Norway (NO)
- ATC code
- L04AA28
- ATC class
- Belatacept
- Defined daily dose
- 12.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_936C27BE-3179-472F-9C19-01C0265DC6FC
- no_varenummer109242250NOK 4688.1
- gtin8027950502295
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
62 interactions on record for belatacept.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Belatacept · interactions on record
62 records
- 29 severe
- 26 moderate
- 7 minor
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Belatacept in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNULOJIXBristol-Myers Squibb Pharma EEIG, Dublin
- SpainNULOJIX 250 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONBristol-Myers Squibb Pharma Eeig
- FinlandNulojixBristol-Myers Squibb Pharma EEIG
- United KingdomNulojix 250mg powder for concentrate for solution for infusion vialsBristol-Myers Squibb Pharmaceuticals Ltd
- IrelandNULOJIX 250 mg powder for concentrate for solution for infusionBristol-Myers Squibb Pharma EEIG
- IcelandNulojixBristol-Myers Squibb Pharma EEIG*
- PolandNulojixBristol-Myers Squibb Pharma EEIG
- BelgiumNulojix 250 mgBristol-Myers Squibb Pharma
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Nulojix
- Liechtenstein · Nulojix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d48dc572-a018-49ea-b26d-e7219ce7440a GET /v1/drugs/d48dc572-a018-49ea-b26d-e7219ce7440a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Belatacept",
"merkevare_id": "ID_936C27BE-3179-472F-9C19-01C0265DC6FC",
"name_form_strength": "Nulojix pulv til kons til inf væske, oppl 250 mg",
"prescription_group": "C"
}See everything about belatacept.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.